发布求助
文献互助 智能选刊 最新文献

Revue Du Praticien最新文献

筛选
英文 中文
[Impact of the environment on health. Part 1. Child: the concept of the first 1 000 days]. 环境对健康的影响。第1部分。儿童:最初1000天的概念]。
Revue Du Praticien Pub Date : 2023-06-01
Umberto Simeoni, Jean-Baptiste Armengaud
{"title":"[Impact of the environment on health. Part 1. Child: the concept of the first 1 000 days].","authors":"Umberto Simeoni, Jean-Baptiste Armengaud","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 6","pages":"679-685"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10035573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ollier disease]. (奥丽疾病)。
Revue Du Praticien Pub Date : 2023-06-01
Habib Bellamlih, Oumaima El Bouazzi, Soufiane Belabbes, Abdellatif El Haddad, Brahim Zinoun, Taoufik Africha
{"title":"[Ollier disease].","authors":"Habib Bellamlih, Oumaima El Bouazzi, Soufiane Belabbes, Abdellatif El Haddad, Brahim Zinoun, Taoufik Africha","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 6","pages":"657"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10042540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pain in children. Assessment and analgesic treatments]. 儿童疼痛。评估和镇痛治疗]。
Revue Du Praticien Pub Date : 2023-06-01
Anne Defontaine, Claude Ecoffey
{"title":"[Pain in children. Assessment and analgesic treatments].","authors":"Anne Defontaine, Claude Ecoffey","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 6","pages":"687-692"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10042542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Frontline therapy for classical Hodgkin lymphoma patients]. [经典霍奇金淋巴瘤患者的一线治疗]。
Revue Du Praticien Pub Date : 2023-06-01
Cédric Rossi, Olivier Casasnovas
{"title":"[Frontline therapy for classical Hodgkin lymphoma patients].","authors":"Cédric Rossi,&nbsp;Olivier Casasnovas","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>FRONTLINE THERAPY FOR CLASSICAL HODGKIN LYMPHOMA PATIENTS. Upfront first-line chemotherapy is indicated for all features of classical Hodgkin's lymphoma, followed by involved node radiotherapy in early stages; the ABVD protocol (doxorubicin (Adriamycin), bleomycin, vinblastine, dacarbazine) is the international standard of care. The 7-agent BEACOPP protocol (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine (Oncovin), procarbazine, prednisone) is used in advanced stages in its «escalated» version (BEAesc). During the 2010 decade, it has been demonstrated that strategies guided by positron emission tomography (PET) allows optimizing the benefit/risk ratio of the treatment by decreasing the intensity of therapies for good responders and intensifying treatment of poor responders. Thus, early PET response evaluation is now essential to adapt the treatment intensity. Despite these major advances, several issues remain, including the management of acute and long-term side effects of first-line treatments, the better options for refractory patients, the place and optimization of radiotherapy, and the place for new therapeutic agents such as the anti-CD30 conjugate antibody (brentuximab vedotin) and PD-1 inhibitors in the first-line treatment setting.</p>","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 6","pages":"625-632"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10189518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hodgkin lymphoma: 10 key messages]. [霍奇金淋巴瘤:10个关键信息]。
Revue Du Praticien Pub Date : 2023-06-01
Hervé Ghesquières
{"title":"[Hodgkin lymphoma: 10 key messages].","authors":"Hervé Ghesquières","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 6","pages":"654"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10042535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A better understanding of biological mechanisms]. [更好地理解生物机制]。
Revue Du Praticien Pub Date : 2023-06-01
Hervé Ghesquières
{"title":"[A better understanding of biological mechanisms].","authors":"Hervé Ghesquières","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 6","pages":"615-616"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10042536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Let's ride against prostate cancer!] 让我们骑马对抗前列腺癌!]
Revue Du Praticien Pub Date : 2023-06-01
Alexandre De la Taille
{"title":"[Let's ride against prostate cancer!]","authors":"Alexandre De la Taille","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 6","pages":"599-600"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10042537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Fertility and gonadal disorders in patients with Hodgkin lymphoma]. [霍奇金淋巴瘤患者的生育和性腺功能障碍]。
Revue Du Praticien Pub Date : 2023-06-01
Christine Rousset-Jablonski
{"title":"[Fertility and gonadal disorders in patients with Hodgkin lymphoma].","authors":"Christine Rousset-Jablonski","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 6","pages":"651-653"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10042541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The history of Hodgkin lymphoma]. 【霍奇金淋巴瘤的病史】。
Revue Du Praticien Pub Date : 2023-06-01
Christophe Fermé
{"title":"[The history of Hodgkin lymphoma].","authors":"Christophe Fermé","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>THE HISTORY OF HODGKIN LYMPHOMA. Hodgkin lymphoma was initially considered to be caused by infectious agents. The Hodgkin and Reed-Sternberg tumor cells are derived from mature B cells and transforming events were identified. Staging laparotomy has been discontinued for clinical evaluation with the progress of medical imaging. For seven decades, clinical trials have allowed to define risk factors, to improve standard treatments with the optimal use of chemotherapy and radiotherapy. A risk adapted strategy and early response to chemotherapy are mandatory to reduce long-term consequences of treatment.</p>","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 6","pages":"608-610"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10189519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Toxicity of targeted therapies and immunotherapy with checkpointinhibitors in Hodgkin lymphoma]. [靶向治疗和检查点抑制剂免疫治疗在霍奇金淋巴瘤中的毒性]。
Revue Du Praticien Pub Date : 2023-06-01
Jean-Marie Michot, Julien Lazarovici
{"title":"[Toxicity of targeted therapies and immunotherapy with checkpointinhibitors in Hodgkin lymphoma].","authors":"Jean-Marie Michot,&nbsp;Julien Lazarovici","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>TOXICITY OF TARGETED THERAPIES AND IMMUNOTHERAPY WITH CHECKPOINT INHIBITORS IN HODGKIN LYMPHOMA. In patients at increased risk of recurrence or progression after autotransplantation, or in cases of relapse after autotransplantation or after at least two lines of treatment when intensive multidrug therapy is no longer a treatment option, targeted anti-CD30 therapy with brentuximab vedotin may be proposed. Brentuximab vedotin is a monoclonal antibody directed against CD30 and coupled with an anti-microtubule cytotoxic agent, monomethyl auristatin E (MMAE). The main adverse side effect of brentuximab vedotin is peripheral neuropathy. In patients who have relapsed after intensive chemotherapy, including autograft for patients eligible for this treatment, and after failure of brentuximab vedotin, anti-PD1 immunotherapy (nivolumab or pembrolizumab) may be offered. Anti-PD1 (Programmed cell death protein 1) side effects are immune-related, varied and unpredictable (endocrinopathies, rash, colitis, interstitial lung disease). The tolerability profiles of brentuximab vedotin and anti-PD1 and the management of the main undesirable side effects of these treatments are detailed for clinical practice.</p>","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 6","pages":"641-650"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10189522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信